[1]
Nichele, I. et al. 2024. Tailored therapy with turoctocog alfa pegol according to patient’s lifestyle and hemorrhagic phenotype: from clinical trial to real-life. Bleeding, Thrombosis and Vascular Biology. 3, 1 (Apr. 2024). DOI:https://doi.org/10.4081/btvb.2024.104.